Cognyte Software Ltd. CGNT 深 沪
等待开盘 09-11 09:30:00 美东时间
8.26
-0.190
-2.25%
华盛通- 最 高8.54
- 今 开8.37
- 成交量 35.62万股
- 最 低 8.2102
- 昨 收 8.45
- 总市值 6.03亿
- 52周最高 11.655
- 市盈率 静 --
- 换手率 0.49%
- 52周最低 6.38
- 委 比 -60.55%
- 总股本 7296.91万
- 历史最高 33.50
- 量 比 0.66
- 振 幅 3.90%
- 历史最低 0.672
- 每 手 1
- 风险率 1.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cognyte Software Ltd. Reports Strong Q2 Growth
Cognyte Software Ltd. (($CGNT)) has held its Q2 earnings call. Read on for the ...
09-10 08:03
Cognyte Software shares are trading lower. The company reported Q2 financial results.
Cognyte Software shares are trading lower. The company reported Q2 financial re...
09-09 23:13
Earnings Scheduled For September 9, 2025
Companies Reporting Before The Bell • Core & Main (NYSE:CNM) is projected t...
09-09 16:32
What's Next: Cognyte Software's Earnings Preview
Cognyte Software (NASDAQ:CGNT) is set to give its latest quarterly earnings rep...
09-08 23:00
Cognyte Software Holds Successful Annual Shareholder Meeting
Cognyte Software ( ($CGNT) ) has provided an update. On September 4, 2025, Cogn...
09-05 18:58
传Thoma Bravo接近收购呼叫中心软件制造商Verint系统(VRNT.US) 估值约20亿美元
知情人士透露，Thoma Bravo即将达成收购呼叫中心软件制造商Verint系统(VRNT.US)的交易，这笔交易对Verint的估值约为20亿美元，包括债务。
08-25 09:47
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results
Cogent Biosciences reported positive results from the SUMMIT trial for bezuclastinib in NonAdvanced Systemic Mastocytosis patients, achieving statistical significance across primary and key secondary endpoints. The company also announced financial results, securing $800 million in capital through debt financing and a public offering, positioning it to fund operations through 2027. Upcoming milestones include top-line results from PEAK and APEX tr...
08-05 12:00
Needham Reiterates Hold on Cognyte Softwareto Hold
Needham analyst Mike Cikos reiterates Cognyte Software (NASDAQ:CGNT) from Hold to Hold.
07-28 17:51
Cognyte Wins $10M Deal With Tier 1 EMEA Military, Replacing Incumbent With Superior SIGINT Technology
New customer selects Cognyte over incumbent, citing superior technology, regional references and proven operational valueCognyte Software Ltd. (NASDAQ:CGNT) ("Cognyte"), a global leader in software-driven technology for
07-23 21:49
